Literature DB >> 16533486

The vascular Ehlers-Danlos syndrome.

Dominique P Germain1.   

Abstract

Vascular Ehlers-Danlos syndrome (EDS) is a life-threatening inherited disorder of connective tissue causing severe arterial and gastrointestinal fragility and rupture, as well as complications of surgical and radiologic interventions. The diagnosis should be considered in patients under the age of 45 years who present with arterial tearing or dissection, colonic perforation, or visceral rupture. As for many orphan diseases, delayed diagnosis can lead to inaccurate care. Therefore, vascular EDS is particularly important to surgeons, radiologists, and obstetricians because knowledge of the diagnosis may help in the management of visceral complications. There are currently no specific treatments for this genetic condition, and medical intervention is limited to symptomatic treatment, precautionary measures, genetic counseling, and prenatal diagnosis. A clinical trial is ongoing to study the effectiveness of beta blockers with vasodilating properties in vascular EDS. Complications require hospitalization, observation in an intensive care unit, and sometimes emergency surgical intervention. CT, echography, and MRI are the most useful imaging modalities. Arteriography is contraindicated. Whenever possible, a wait-and-see attitude with close surveillance is preferable to unwarranted surgery. Surgical treatment carries a high mortality, whereas the mortality rate associated with endovascular treatment is unknown. To improve the likelihood of good surgical outcome, the surgeon must be informed of the patient's condition. The intent of surgery is to control hemorrhage if an artery, with or without aneurysm, has ruptured and to reconstruct the arterial vasculature. For vascular repair, simple procedures should be preferred, because more complex techniques can result in further injury and hemorrhage. Postoperative surveillance must be prolonged with close medical follow-up and serial CT scans. Pregnant women with vascular EDS should be considered high-risk cases and be provided special care.

Entities:  

Year:  2006        PMID: 16533486     DOI: 10.1007/s11936-006-0004-z

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  35 in total

1.  Skin manifestations, multiple aneurysms, and carotid-cavernous fistula in Ehlers-Danlos syndrome type IV.

Authors:  J H Koh; J S Kim; S C Hong; Y H Choe; Y S Do; H S Byun; W R Lee; D K Kim
Journal:  Circulation       Date:  1999-09-28       Impact factor: 29.690

2.  Combination therapy of DDAVP and conjugated estrogens for a recurrent large subcutaneous hematoma in Ehlers-Danlos syndrome.

Authors:  Hiroshi Yasui; Yasushi Adachi; Takae Minami; Tadao Ishida; Yasuo Kato; Kohzoh Imai
Journal:  Am J Hematol       Date:  2003-01       Impact factor: 10.047

3.  COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture.

Authors:  F M Pope; P Narcisi; A C Nicholls; D Germaine; G Pals; A J Richards
Journal:  Br J Dermatol       Date:  1996-08       Impact factor: 9.302

4.  Emergency repair of type A aortic dissection in type IV Ehlers-Danlos syndrome.

Authors:  R Ascione; W J Gomes; M Bates; J L Shannon; F M Pope; G D Angelini
Journal:  Cardiovasc Surg       Date:  2000-01

Review 5.  Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders.

Authors:  Anne De Paepe; Fransiska Malfait
Journal:  Br J Haematol       Date:  2004-12       Impact factor: 6.998

6.  Spontaneous coronary artery rupture and cardiac tamponade in Ehlers-Danlos syndrome type IV.

Authors:  R H Evans; A G Fraser
Journal:  Int J Cardiol       Date:  1996-06       Impact factor: 4.164

7.  Fatal hemoptysis in Ehlers-Danlos syndrome. Old malady with a new curse.

Authors:  B A Yost; J P Vogelsang; J T Lie
Journal:  Chest       Date:  1995-05       Impact factor: 9.410

8.  Cerebrovascular Involvement in Ehlers-Danlos Syndrome.

Authors:  Wouter I. Schievink
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

9.  Myocardial infarction and coronary artery dissection during pregnancy associated with type IV Ehlers-Danlos syndrome.

Authors:  A M Athanassiou; M A Turrentine
Journal:  Am J Perinatol       Date:  1996-04       Impact factor: 1.862

10.  Intracranial aneurysm surgery in Ehlers-Danlos syndrome Type IV.

Authors:  Wouter I Schievink; Michael J Link; David G Piepgras; Robert F Spetzler
Journal:  Neurosurgery       Date:  2002-09       Impact factor: 4.654

View more
  4 in total

1.  Coronary abnormalities in hyper-IgE recurrent infection syndrome: depiction at coronary MDCT angiography.

Authors:  Ahmed M Gharib; Roderic I Pettigrew; Abdalla Elagha; Amy Hsu; Pam Welch; Steven M Holland; Alexandra F Freeman
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

2.  Coronary artery abnormalities in Hyper-IgE syndrome.

Authors:  Alexandra F Freeman; Elizabeth Mannino Avila; Pamela A Shaw; Joie Davis; Amy P Hsu; Pamela Welch; Jatin R Matta; Colleen Hadigan; Roderic I Pettigrew; Steven M Holland; Ahmed M Gharib
Journal:  J Clin Immunol       Date:  2011-04-15       Impact factor: 8.542

3.  Ehlers-Danlos Syndrome Presenting as Severe Headache in a Young Adult.

Authors:  Sara R Alcorn; Marie-Adele Sorel; Stephan Auerbach; Kitt Shaffer
Journal:  Radiol Case Rep       Date:  2015-12-07

Review 4.  Ehlers-Danlos syndrome type IV.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2007-07-19       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.